1 ADHD Program, Hospital de Clinicas de Porto Alegre, Rua Ramiro Barcelos, 2350-2201, Porto Alegre, RS, 90035-003, Brazil Tel.: +55 513 321 3946 Fax: +55 513 321 3946 lrohde@terra.com.br ...

Those randomised to 25-minute daily use of SDT-001 for six weeks saw statistically significant improvements in the change from baseline in the ADHD Rating Scale IV (ADHD-RS-IV) Inattention score ...

1 ADHD Program, Hospital de Clinicas de Porto Alegre, Rua Ramiro Barcelos, 2350-2201, Porto Alegre, RS, 90035-003, Brazil Tel.: +55 513 321 3946 Fax: +55 513 321 3946 lrohde@terra.com.br ...

Analyses across four studies in paediatric ADHD showed that overall 34.5% of children moved into the normative range on at least one measure of attention following four weeks of EndeavorRx treatment.

Study participants were randomly assigned to receive CTx-1301 18.75mg, 25mg, 37.5mg, or placebo for 5 weeks; patients randomized to CTx-1301 received a starting dose of 12.5mg and then were ...

ADHD can be a lifelong problem, bringing different challenges at different times, and it’s important that you, your child, and your doctor meet regularly so that you can best meet those challenges.

Remarkably, a comparison of pharmacogenetics of ADHD evidences a striking increase in the number of published articles (Figure 1). Here, we provide an updated review of the literature, presenting ...

Abbass, K., Corbisiero, S., & Stieglitz, R. D. (2021). Development and psychometric properties of the ADHD-SCL-90-R screening scale for adult ADHD. Journal of ...

Citizens JMP analyst firm reiterated its Market Outperform rating and $36.00 price target on Option Care Health (NASDAQ: OPCH) following meetings with company executives.According to InvestingPro ...